Regulated methionine oxidation by monooxygenases.

Biological systems rely on controlled chemical modifications to regulate protein function. While cysteine oxidation is well understood, methionine oxidation has remained less clear. Traditional models suggest reactive oxygen species (ROS) cause non-specific oxidation, followed by enzymatic repair. However, methionine oxidation by ROS is too slow to be biologically significant. Despite this, methionine oxidation is observed in vivo, and reductases exist across all life domains. This discrepancy raises questions about the mechanisms and regulation of methionine oxidation. Prior research has shown that oxidation of methionine is not random but may be enzyme-mediated. This gap motivated researchers to investigate whether methionine oxidation is a regulated process. That uncertainty drove the exploration of monooxygenase enzymes and their role in methionine modification. No prior work had resolved the enzymatic basis of methionine oxidation in a targeted, reversible manner.

The aim of this study is to examine the enzymatic regulation of methionine oxidation and its biological implications. Methionine oxidation is observed in vivo, but the mechanisms remain unclear. The researchers propose that monooxygenases, rather than ROS, may be responsible for controlled oxidation. This paper seeks to clarify the role of MICALs, a newly identified family of flavin-dependent monooxygenases. The study investigates the structural and kinetic properties of these enzymes. The researchers also aim to understand how methionine oxidation is reversed by reductases. This work addresses a gap in redox signaling research by exploring methionine as a regulatory residue. The findings may redefine methionine oxidation as a reversible, enzyme-controlled process.

The study employs a combination of biochemical and structural analyses to investigate methionine oxidation. Researchers focused on MICAL proteins, which contain a flavin-monooxygenase domain. They used kinetic assays to measure the oxidation activity of MICALs. Structural models were generated to explain the mechanism of methionine sulfoxidation. The team also examined the role of NADPH in the oxidation process. They compared the oxidation rates of methionine by MICALs versus ROS. The study included analysis of methionine sulfoxide reductases to assess the reversibility of oxidation. This approach allowed the researchers to propose a regulatory framework for methionine oxidation.

MICAL proteins were found to catalyze methionine oxidation in a stereoselective manner. The oxidation reaction is NADPH-dependent and occurs at a biologically relevant rate. Structural analysis revealed a conserved active site in MICALs that binds methionine. Kinetic data showed that MICALs have a higher specificity for methionine than ROS. The oxidation product is methionine sulfoxide, which is reduced by methionine sulfoxide reductases. This suggests a reversible system for methionine modification. The study found that MICALs are inhibited by flavin analogs and redox conditions. These findings indicate that methionine oxidation is an enzyme-regulated process.

The authors propose that methionine oxidation is a regulated, enzyme-mediated process. MICALs are identified as key enzymes in this pathway. The oxidation of methionine is reversible, suggesting a dynamic regulatory mechanism. This process is analogous to phosphorylation by kinases and phosphatases. The study suggests that methionine oxidation may serve as a signaling mechanism. The findings indicate that MICALs are responsible for stereoselective oxidation. The presence of reductases supports the idea of reversible modification. These conclusions suggest that methionine oxidation is a controlled process with functional implications.